Indicators of Response to the Wee1 Inhibitor Adavosertib in Acute Myeloid Leukemia

被引：0
|
作者：
Srivastava, Ankita [1 ]
Heckman, Caroline A. [1 ,2 ,3 ,4 ,5 ,6 ]
Miettinen, Juho Jalmari [3 ]
Harismendy, Olivier [7 ]
机构：
[1] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland
[2] Inst Mol Med Finland FIMM, Helsinki, Finland
[3] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki Inst Life Sci, Helsinki, Finland
[4] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki Inst Life Sci, ICAN Digital Precis Canc Med Flagship, Helsinki, Finland
[5] Univ Helsinki, Inst Mol Med Finland FIMM, HiLIFE, Helsinki, Finland
[6] Univ Helsinki, ICAN Digital Precis Canc Ctr Med Flagship, Helsinki, Finland
[7] Zentalis Pharmaceut, Translat Data Sci & Computat Biol, San Diego, CA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-188608
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma
    Liu, Joyce F.
    Xiong, Niya
    Campos, Susana M.
    Wright, Alexi A.
    Krasner, Carolyn
    Schumer, Susan
    Horowitz, Neil
    Veneris, Jennifer
    Tayob, Nabihah
    Morrissey, Stephanie
    West, Gabriela
    Quinn, Roxanne
    Matulonis, Ursula A.
    Konstantinopoulos, Panagiotis A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (14) : 1531 - +
  • [2] WEE1 AS A THERAPEUTIC TARGET IN ACUTE LEUKEMIA
    Ford, James
    Baturin, Dmitry
    Van Linden, Annemie
    Fosmire, Susan
    Porter, Chris
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S39 - S40
  • [3] Wee1激酶抑制剂adavosertib
    谭烨
    奉源
    魏会强
    李祎亮
    韩英梅
    现代药物与临床, 2018, 33 (04) : 989 - 996
  • [4] A Phase Ib study of Wee1 inhibitor adavosertib in patients with advanced solid tumors
    Falchook, Gerald S.
    Sachdev, Jasgit
    Imedio, Esteban Rodrigo
    Kumar, Sanjeev
    Mugundu, Ganesh
    Chmielecki, Juliann
    Jones, Suzanne
    Spigel, David R.
    Johnson, Melissa
    CANCER RESEARCH, 2019, 79 (13)
  • [5] Targeting the Wee1 Kinase for Treatment of Pediatric Down Syndrome Acute Myeloid Leukemia
    Caldwell, J. Timothy
    Edwards, Holly
    Buck, Steven A.
    Ge, Yubin
    Taub, Jeffrey W.
    PEDIATRIC BLOOD & CANCER, 2014, 61 (10) : 1767 - 1773
  • [6] ADAVOSERTIB, A WEE1 INHIBITOR, AS A NOVEL SENOLYTICS, TARGETS THE VULNERABILITY OF LIVER CANCER INDUCED BY EPIRUBICIN
    Song, Penghong
    GASTROENTEROLOGY, 2024, 166 (05) : S1732 - S1732
  • [7] Adavosertib and beyond: Biomarkers, drug combination and toxicity of WEE1 inhibitors
    Zhang, Chi
    Peng, Ke
    Liu, Qing
    Huang, Qihong
    Liu, Tianshu
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 193
  • [8] Targeting WEE1 by adavosertib inhibits the malignant phenotypes of hepatocellular carcinoma
    Chen, Jian
    Jia, Xing
    Li, Zequn
    Song, Wenfeng
    Jin, Cheng
    Zhou, Mengqiao
    Xie, Haiyang
    Zheng, Shusen
    Song, Penghong
    BIOCHEMICAL PHARMACOLOGY, 2021, 188
  • [9] WEE1 and PARP-1 play critical roles in myelodysplastic syndrome and acute myeloid leukemia treatment
    Seiichi Okabe
    Yuko Tanaka
    Mitsuru Moriyama
    Akihiko Gotoh
    Cancer Cell International, 23
  • [10] Targeted inhibition of the methyltransferase SETD8 synergizes with the Wee1 inhibitor adavosertib in restraining glioblastoma growth
    Rosa Della Monica
    Michela Buonaiuto
    Mariella Cuomo
    Cristina Pagano
    Federica Trio
    Davide Costabile
    Giulia de Riso
    Francesca Sveva Cicala
    Maddalena Raia
    Raduan Ahmed Franca
    Marialaura Del Basso De Caro
    Domenico Sorrentino
    Giovanna Navarra
    Laura Coppola
    Lorella Tripodi
    Lucio Pastore
    Juergen Hench
    Stephan Frank
    Claudio Schonauer
    Giuseppe Catapano
    Maurizio Bifulco
    Lorenzo Chiariotti
    Roberta Visconti
    Cell Death & Disease, 14
12345